Ozaki, Masakuni published the artcileIn vivo antibacterial activity of a prodrug of NM394, a thiazetoquinoline carboxylic acid derivative, Recommanded Product: Ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate, the main research area is thiazetoquinoline prodrug NM441 NM394 antibacterial.
NM394 (6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]-thiazeto[3,2-a]quinoline-3-carboxylic acid) has potent, broad-spectrum antibacterial activity in vitro, but not in vivo. To increase the bioavailability of NM394, various prodrugs were synthesized and tested. One of them, NM441, an N-(5-methyl-2-oxo-1,3-dioxol-4-yl) derivative, showed potent in vivo antibacterial activity. Using thin-layer chromatog.-bioautog., it was confirmed that after oral administration, NM441 was readily absorbed and hydrolyzed to NM394. Other prodrugs of NM394 were only partially metabolized to NM394. In pharmacokinetic studies in mice and monkeys, it was found that the blood levels of NM394 were 7.8 and 5.9 × greater, resp., when NM441 rather than NM394 was administered. These findings suggest that NM441 is an effective prodrug of NM394.
Chemotherapy (Basel) published new progress about Antimicrobial agents. 113028-17-4 belongs to class piperazines, name is Ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate, and the molecular formula is C18H20FN3O3S, Recommanded Product: Ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate.
Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics